Roopal Thakkar - 27 Feb 2026 Form 4 Insider Report for AbbVie Inc. (ABBV)

Reporting relationship: EVP, R&D and CSO
Issuer ticker: ABBV
Reported as of: 27 Feb 2026
Net transaction value: -$1,865,227
SEC form: 4
Accepted by SEC: 03 Mar 2026, 18:14:39 UTC
Prior SEC filing: 20 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ T.O. Odutayo, Attorney-in-Fact for Roopal Thakkar

Key filing fact

Roopal Thakkar filed Form 4 for AbbVie Inc. (ABBV) on 03 Mar 2026.

Key facts

This page summarizes Roopal Thakkar's Form 4 filing for AbbVie Inc. (ABBV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Mar 2026, 18:14.

Change

Previous filing in this sequence was filed on 20 Feb 2026.
Current net transaction value: -$1,865,227.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002004979 Primary reporting owner

Thakkar Roopal

Relationship: EVP, R&D and CSO
Address: 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO
Signature: /s/ T.O. Odutayo, Attorney-in-Fact for Roopal Thakkar
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABBV transaction

Common Stock, $0.01 par value

Tax liability

Transaction value: $1,865,227
Shares: -8,037
Change %: -13%
Price: $232.08
Shares after: 52,376
Date: 27 Feb 2026
Ownership: Direct

ABBV holding

Common Stock, $0.01 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,998
Date: 27 Feb 2026
Ownership: Profit sharing trust
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature. This was inadvertently omitted from the Form 3 filed on December 22, 2023.